Internal Medicine, Infectious Disease · Bronx, NY
NPI
1104916907
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
Mmc - Dept. of Medicine, 3400 Bainbridge Avenue, 2nd Fl
Bronx, NY, 10467
Phone (718) 920-7364
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
478 services
Medicare patients, 2024
281
Average age 71
Drug cost, 2024
$8.8M
9,243 prescriptions
Company payments, 2025
$3,114
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Peter L Alpert was code 99232 (hospital e&m - subsequent), 131 times for 101 patients. In total Peter L Alpert billed 478 services in 13 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 131 | 101 | $70.97 | $9,298 |
| 99213 Office E&M - Established | Facility | 99 | 59 | $51.33 | $5,082 |
| 99231 Hospital E&M - Subsequent | Facility | 68 | 54 | $46.44 | $3,158 |
| 99214 Office E&M - Established | Facility | 64 | 55 | $75.98 | $4,863 |
| 99223 Hospital E&M - Initial | Facility | 42 | 42 | $162.59 | $6,829 |
| 99233 Hospital E&M - Subsequent | Facility | 32 | 31 | $113.74 | $3,640 |
| 99222 Hospital E&M - Initial | Facility | 27 | 27 | $116.67 | $3,150 |
By year: 2022 $34K for 444 services; 2023 $41K for 542 services; 2024 $37K for 478 services.
Medicare prescription drug claims, 2024
In 2024, the drug Peter L Alpert prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 630 prescriptions and refills. In total Peter L Alpert wrote 9,243 Medicare prescriptions that cost $8.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 630 | 664 | 71 | $2.5M |
| Dovato Dolutegravir Sodium/Lamivudine | 482 | 486 | 49 | $1.4M |
| Atorvastatin Calcium Generic | 463 | 653 | 70 | $2,738 |
| Descovy Emtricitabine/Tenofov Alafenam | 350 | 378 | 42 | $787K |
| Zolpidem Tartrate Generic | 327 | 327 | 44 | $1,061 |
| Amlodipine Besylate Generic | 301 | 398 | 46 | $1,003 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 285 | 293 | 42 | $8,935 |
| Tivicay Dolutegravir Sodium | 217 | 223 | 25 | $532K |
| Valacyclovir Valacyclovir Hcl | 208 | 220 | 30 | $3,988 |
| Rosuvastatin Calcium Generic | 166 | 194 | 24 | $827 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 158 | 160 | 17 | $550K |
| Gabapentin Generic | 154 | 162 | 22 | $804 |
| Omeprazole Generic | 148 | 166 | 21 | $425 |
| Metformin Hcl Generic | 137 | 189 | 18 | $567 |
| Losartan Potassium Generic | 135 | 199 | 26 | $907 |
Brand drugs: 3,401 claims; generic drugs: 5,730 claims; opioid claims: 213.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Peter L Alpert $3,114 ($3,114 in general payments such as food, travel and fees) from 5 companies. The largest payer was ViiV Healthcare Company with $1,440.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.